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Abstract 
Angioimmunoblastic T-cell lymphoma (AITCL) is a rare, aggressive lymphoma which derives 
from follicular helper T cells, commonly affecting the elderly population. It accounts for 2% of 
all non-Hodgkin lymphomas, with a reported 5-year overall survival rate of less than 30%. 
Very often, the clinical picture of AITCL encompasses systemic symptoms such as generalized 
lymphadenopathy, hepatosplenomegaly, skin rash, anemia, and polyclonal hypergamma-
globulinemia. Here we report on the case of a female patient who presented with clinical 
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features resembling drug reaction with eosinophilia and systemic symptoms (DRESS syn-
drome) prior to the definitive diagnosis of AITCL. The index of suspicion for cutaneous mani-
festations of lymphoma, and especially AITCL, must be high, particularly in atypical clinical 
courses of drug eruptions or if skin lesions relapse and are refractory to standard high-dose 
systemic corticosteroids. © 2017 The Author(s) 
 Published by S. Karger AG, Basel 
Case Report 
A 65-year-old, otherwise healthy female patient presented to our emergency depart-
ment with an erythematous, confluent, itchy, maculopapular exanthema on her trunk and 
extremities which had started 7 days before admission. In addition, she complained of a 
gradual onset of malaise, weight loss, arthralgia, and night sweats, having lasted about 3 
weeks. The initial diagnosis was parainfectious exanthema. Topical and systemic steroids 
(prednisone 50 mg) were prescribed and the patient was discharged. Four days later, she 
revisited our department with facial edema and with the exanthema now having spread all 
over her body. On admission, she was afebrile with normal vital signs. A detailed medication 
history was obtained. The patient confirmed having taken diclofenac once and stimulant 
laxatives 5 months and 6 weeks before the onset of exanthema, respectively. Furthermore, 
local dental anesthesia had been performed 2 weeks before symptom onset, and she had 
been on St. John’s wort (Hypericum perforatum) for minor depression for 1 year. 
A physical examination revealed cervical lymphadenopathy, splenomegaly, and sub-
erythroderma (Fig. 1). Laboratory tests showed mild leukocytosis (10.65 G/L) with atypical 
lymphocytes in the peripheral blood smear, mild anemia (Hb 116 g/L), eosinophilia (1.20 
G/L), and mildly elevated AST (40 U/L) and creatinine levels (83 μmol/L). The patient was 
lymphopenic (0.58 G/L) and had normal platelet count (392 G/L). Her lactate dehydrogen-
ase levels were normal. Epstein-Barr virus (EBV) PCR (3,316 copies/mL) and EBV serology 
were positive (Epstein-Barr nuclear antigen IgG and EBV IgG positive; EBV IgM negative). 
Human herpes virus (HHV)-6 and -8 were not reactivated, and HIV and HBV/HCV were neg-
ative. Serum protein electrophoresis, immunofixation, and serum free light chains were un-
remarkable. Chest radiography showed mild mediastinal widening. An abdominal ultra-
sound confirmed splenomegaly (13.7 cm diameter) and showed retroperitoneal lymphade-
nopathy. A skin biopsy, performed at presentation, revealed spongiotic dermatitis with peri-
vascular lymphocytic infiltration with eosinophils (Fig. 2a). Histologically, eczema versus 
eczematous drug reaction was discussed. No signs of atypical lymphocytic infiltration were 
noted. 
In view of the exanthema, eosinophilia, facial edema, lymphadenopathy with systemic 
involvement, and medication history, as well as taking into account the histology report, a 
diagnosis of drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) 
with an atypical reactivation of EBV was proposed. Diclofenac and articaine were considered 
as possible causative medications. In support of this, a lymphocyte transformation test de-
tected T-cell sensitization against diclofenac. The patient was treated with intravenous corti-
costeroids followed by oral prednisone (1 mg/kg) upon improvement. Topical emollients to 
relieve the skin tenderness were applied. 
Despite clinical improvement upon treatment, her originally reported weight loss and 
night sweats remained, while the skin lesions and lymphadenopathy became progressively 
severe. The patient was readmitted to our clinic, where another skin biopsy was performed, 
and the histological findings were similar to the previous ones, again in support of a drug 
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reaction (Fig. 2b). However, the course of the disease, as well as thoracic and abdominal CT 
scans, revealed generalized lymphadenopathy and splenomegaly (16.4 cm), which directed 
our suspicion towards a hematological disease. An inguinal lymph node excision biopsy was 
conducted, showing lymphocyte hyperplasia with effacement of the normal architecture and 
high vascular proliferation with an increased number of CD23+ follicular dendritic cells. The 
cellular infiltrate consisted of a monomorphic, small- to medium-sized population of lym-
phocytes CD3+/CD4+ with coexpression of programmed cell death protein 1 (PD1), and of 
abundant lymphoid cells partly with a blastic morphology and plasma cell differentiation. 
Expression of CD79a and, partially, CD20 for the B cells and of CD30 for the large lymphoid 
blasts was noted. The atypical cells were negative for anaplastic lymphoma kinase. Epstein-
Barr encoding region (EBER) in situ hybridization revealed EBER-positive nuclei, and our 
patient was finally diagnosed with angioimmunoblastic T-cell lymphoma (AITCL). Her bone 
marrow revealed no further pathological findings. 
The patient was subsequently referred to the hemato-oncology unit for further treat-
ment. She underwent CHOP (cyclophosphamide-hydroxydaunorubicin-oncovin-prednisone) 
chemotherapy followed by autologous stem cell transplantation. Unfortunately, 3 months 
after stem cell transplantation her disease rapidly progressed and she was put on IGEV 
(ifosfamide, gemcitabine, and vinorelbine) salvage chemotherapy. At the last follow-up, the 
patient was in a poor general condition, and she was admitted to a palliative care unit, where 
she deceased few days afterwards. 
Discussion 
AITCL is a rare, aggressive lymphoma which derives from follicular T-helper cells of the 
germinal center of the secondary lymphoid organs, commonly affecting the elderly popula-
tion, with a reported 5-year overall survival rate of less than 30% [1–4]. Specific cutaneous 
infiltrates can be the first manifestation of AITCL; however, nonspecific skin manifestations 
such as maculopapular exanthema, purpura, and erythroderma occur in approximately half 
of the patients [5]. In more than one-third of these cases, a drug – mostly an antibiotic – has 
been chronologically associated with the onset of the disease. Furthermore, it has been asso-
ciated with several viral infections such as tuberculosis, Cryptococcus neoformans infection, 
and lymphotropic virus infection. The best evidence currently available implicates EBV in its 
pathogenesis, since EBV-infected cells have been found in nearly all AITCL patients. This 
suggests a dynamic interplay, indicating either that the viral infection plays an active role in 
the pathogenesis and progression of AITCL or that the viral infection is secondary due to 
immune dysregulation during disease progression [6]. Also in our patient, EBER in situ hy-
bridization was positive. The serology showed positive IgG, positive Epstein-Barr nuclear 
antigen IgG, negative IgM, and a positive PCR, a constellation indicative of immune suppres-
sion. 
In this context, DRESS syndrome, a T-cell-mediated, delayed-type IV, potentially life-
threatening hypersensitivity reaction with maculopapular exanthema, fever, internal organ 
involvement, atypical lymphocytes in peripheral blood, and generalized lymphadenopathy, 
poses a challenging differential diagnosis to AITCL or other lymphoproliferative disorders. 
Even monoclonal T-cell receptor rearrangement has been reported in drug reactions, ren-
dering the diagnosis of DRESS syndrome versus lymphoma more difficult [7]. On the other 
hand, benign reactive lymphoproliferative disorders such as Kikuchi disease or infectious 
mononucleosis are sometimes initially misdiagnosed as lymphoma. Interestingly, over the 
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last years an association of DRESS syndrome with viral reactivation of herpes family mem-
bers (e.g., HHV-6, HHV-7, EBV, and CMV) induced by the causative drug has been demon-
strated in the majority of DRESS syndrome patients, complicating the diagnostic process 
even more – at least in early disease stages [8]. 
Our patient fulfilled the proposed diagnostic criteria for DRESS syndrome: rash, eosino-
philia, and atypical lymphocytes, as well as mild nephritis and hepatitis. Although the histol-
ogy was not specific, showing mainly spongiotic changes with exocytosis of lymphocytes, 
together with the clinical features it was compatible with a spongiotic drug reaction, one of 
the possible histological manifestations of DRESS syndrome. Moreover, the presence of atyp-
ical lymphocytes is a feature of DRESS syndrome, even if it is also likely to be explained in 
the course of EBV reactivation. 
The classic drugs causative of DRESS syndrome are anticonvulsants, allopurinol, sulfon-
amides, antibiotics, and nonsteroidal anti-inflammatory drugs (NSAIDs). Since our patient 
had taken NSAIDs before the symptoms’ onset, and due to a positive lymphocyte transfor-
mation test, we initially diagnosed her with DRESS syndrome caused by NSAIDs. Unique to 
DRESS syndrome is its late onset in relation to the period of introduction of the causative 
drug, which can occur around 3 weeks to 3 months previously, as in our case, and the possi-
ble persistence or worsening of the symptoms despite withdrawal of the offending drug. It 
has been shown that patients with severe systemic involvement have higher numbers of 
CD8+ lymphocytes secreting TNF-α, IFN-γ, and IL-2 than those with mild symptoms, which 
can remain for more than 3 months, explaining the usually prolonged course of DRESS syn-
drome after drug withdrawal [8]. 
However, our patient’s symptoms did not improve after the administration of systemic 
steroids, which is why she underwent a further diagnostic evaluation with an excisional 
lymph node biopsy, the gold standard for the diagnosis of AITCL. In hindsight, our patient’s 
polyarthralgia was likely a paraneoplastic manifestation of AITCL, while the weight loss, 
fever, and night sweats were typical B-type symptoms. 
Recently it has been demonstrated that patients with AITCL harbor a distinct 
CD4+/CD8+/PD1+/CXCL13+/CD10+ follicular T-helper cell population, which, together with 
the detection of a network of CD23+ follicular dendritic cells and EBER+ atypical B cells, is 
specific to the diagnosis [9]. 
There is no standard treatment for AITCL. Anthracycline-based therapeutic regimens 
have elicited limited responses. However, strategies targeting the NF-κB pathway and CD52 
have held some promise. Recently, new insights were gained in the pathobiology and classi-
fication of AITCL using gene expression profiling, opening the field for possible targeted 
therapies [10]. 
In conclusion, findings of an atypical clinical course of drug eruptions, especially DRESS 
syndrome, or a poor response to high-dose systemic corticosteroids, as noted in our case, 
should raise suspicion for underlying AITCL, and further evaluation is highly recommended. 
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Fig. 1. Red confluent patches and plaques involving the trunk and extremities, including the face, with mild 
periorbital and facial edema. 
 
 
 
Fig. 2. a, b Skin biopsy showing spongiotic dermatitis with perivascular lymphocytic infiltration with eo-
sinophils. 
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